Turquoise Derivatives Arm Relaunched Under New LSEG Colors

A view of the City of London
London

Turquoise's derivatives arm will be known going forward as London Stock Exchange Derivatives Market, and will operate under Regulated Market of a Recognized Investment Exchange (RIE) rules, allowing its customers to clear and arrange margin more efficiently under new European Market Infrastructure Regulation (EMIR). Its equities derivatives offerings will continue to range among UK, Russian, and Norwegian listings, while its cash equities business remains owns in consortium by LSEG and the handful of investment banks that first launched the low-cost MTF platform in 2008.

The newly-renamed venue will also offer a new contract beginning on October 7, the FTSE UK Large Cap Super Liquid Index (FTSE UK SLQ) futures index product, for which it is already receiving support from BNP Paribas and Timber Hill Europe, among other market makers and leading investment banks supplying client access to the product.

“This marks an important step in growing a strong, diverse derivatives business in the UK," says Nicholas Bertrand, head of equities and derivatives markets at LSEG. "The Super Liquid futures will provide our derivatives customers with an innovative, alternative way to manage risk on the UK equity market."

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Nasdaq reshuffles tech divisions post-Adenza

Adenza is now fully integrated into the exchange operator’s ecosystem, bringing opportunities for new business and a fresh perspective on how fintech fits into its strategy.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here